1. EARLY PROGRESSION OF DISEASE (POD24) PREDICTS SHORTER SURVIVAL IN MALT LYMPHOMA PATIENTS RECEIVING SYSTEMIC TREATMENT. (12th June 2019) Authors: Conconi, A.; Thieblemont, C.; Cascione, L.; Torri, V.; Kiesewetter, B.; Margiotta‐Casaluci, G.; Gaidano, G.; Raderer, M.; Cavalli, F.; Lopez Guillermo, A.; Johnson, P.W.; Zucca, E. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 179 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. THE RISK OF TRANSFORMATION OF FOLLICULAR LYMPHOMA "TRANSFORMED" BY RITUXIMAB: THE ARISTOTLE STUDY PROMOTED BY THE EUROPEAN LYMPHOMA INSTITUTE. (June 2017) Authors: Federico, M.; Caballero, D.; Marcheselli, L.; Tarantino, V.; Sarkozy, C.; Lopez Guillermo, A.; Wondergem, M.; Kimby, E.; Rusconi, C.; Zucca, E.; Montoto, S.; da Silva, M.G.; Aurer, I.; Paszkiewicz‐Kozik, E.; Cartron, G.; Morschhauser, F.; Alcoceba, M.; Chamuleau, M.; Lockmer, S.; Minoia, C. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 115 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗